UA104320C2 - Фармацевтическая композиция на основе митохондриально-адресованного антиоксиданта для применения в медицинской и ветеринарной офтальмологии - Google Patents

Фармацевтическая композиция на основе митохондриально-адресованного антиоксиданта для применения в медицинской и ветеринарной офтальмологии

Info

Publication number
UA104320C2
UA104320C2 UAA201200325A UAA201200325A UA104320C2 UA 104320 C2 UA104320 C2 UA 104320C2 UA A201200325 A UAA201200325 A UA A201200325A UA A201200325 A UAA201200325 A UA A201200325A UA 104320 C2 UA104320 C2 UA 104320C2
Authority
UA
Ukraine
Prior art keywords
mitochondria
medical
pharmaceutical composition
composition based
targeted antioxidants
Prior art date
Application number
UAA201200325A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Максим Владимирович Скулачев
Original Assignee
Общество С Ограниченной Ответственностью "Мимотех"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество С Ограниченной Ответственностью "Мимотех" filed Critical Общество С Ограниченной Ответственностью "Мимотех"
Publication of UA104320C2 publication Critical patent/UA104320C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B69/00—Dyes not provided for by a single group of this subclass
    • C09B69/001—Dyes containing an onium group attached to the dye skeleton via a bridge

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
UAA201200325A 2009-06-10 2009-06-10 Фармацевтическая композиция на основе митохондриально-адресованного антиоксиданта для применения в медицинской и ветеринарной офтальмологии UA104320C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU2009/000295 WO2010143990A1 (ru) 2009-06-10 2009-06-10 Фармацевтическая композиция для применения в медицинской и ветеринарной офтальмологии

Publications (1)

Publication Number Publication Date
UA104320C2 true UA104320C2 (ru) 2014-01-27

Family

ID=43309061

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201200325A UA104320C2 (ru) 2009-06-10 2009-06-10 Фармацевтическая композиция на основе митохондриально-адресованного антиоксиданта для применения в медицинской и ветеринарной офтальмологии

Country Status (15)

Country Link
US (2) US9724313B2 (ko)
EP (2) EP2441453B1 (ko)
JP (1) JP5659388B2 (ko)
KR (1) KR101478728B1 (ko)
CN (2) CN107362157B (ko)
AU (1) AU2009347921B8 (ko)
BR (1) BRPI0924460A2 (ko)
CA (1) CA2764481C (ko)
EA (1) EA025414B1 (ko)
ES (1) ES2527791T3 (ko)
IL (1) IL216702A0 (ko)
MX (1) MX2011013150A (ko)
UA (1) UA104320C2 (ko)
WO (1) WO2010143990A1 (ko)
ZA (1) ZA201200111B (ko)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA031399B1 (ru) * 2011-06-03 2018-12-28 Общество С Ограниченной Ответственностью "Митотех" Изготовление и использование пероральных фармацевтических композиций на основе митохондриально-адресованных антиоксидантов
CN102327650B (zh) * 2011-08-25 2014-01-22 高家旗 一种人工晶状体植入手术柔性水溶胶辅剂及其制备方法
RU2506086C1 (ru) * 2012-09-07 2014-02-10 Илья Александрович Марков Глазные капли, обладающие противовоспалительным и антибактериальным действием
NZ708821A (en) * 2012-12-19 2020-03-27 Novartis Ag Lfa-1 inhibitor formulations
RU2510264C1 (ru) * 2012-12-21 2014-03-27 Станислав Анатольевич Кедик Офтальмологический препарат в виде глазных капель, содержащий разветвленные полигексаметиленгуанидины
CN103405766B (zh) * 2013-08-06 2016-01-06 温州医学院眼视光研究院 一种贝伐单抗滴眼液及其制备方法
US9308165B2 (en) * 2013-08-22 2016-04-12 Therapeutic Vision, Inc. Composition for treating ocular effects of diabetes
US9320709B2 (en) 2013-08-28 2016-04-26 Presbyopia Therapies Llc Storage stable compositions and methods for the treatment of refractive errors of the eye
US9833441B2 (en) 2013-08-28 2017-12-05 Presbyopia Therapies Llc Compositions and methods for the treatment of presbyopia
US10307408B2 (en) 2013-08-28 2019-06-04 Presbyopia Therapies, LLC Contact lens compositions and methods for the treatment of presbyopia
US9089562B2 (en) 2013-08-28 2015-07-28 Presbyopia Therapies Llc Compositions and methods for the treatment of presbyopia
US10617763B2 (en) 2013-08-28 2020-04-14 Presbyopia Therapies, LLC Compositions and methods for the treatment of presbyopia
US10064818B2 (en) 2013-08-28 2018-09-04 Presbyopia Therapies, LLC Compositions and methods for the treatment of presbyopia
US9844537B2 (en) 2013-08-28 2017-12-19 Presbyopia Therapies Llc Compositions and methods for the treatment of presbyopia
US9968594B2 (en) 2013-08-28 2018-05-15 Presbyopia Therapies Llc Compositions and methods for the treatment of presbyopia
US11179327B2 (en) 2013-08-28 2021-11-23 Lenz Therapeutics, Inc. Compositions and methods for the treatment of presbyopia
US9314427B2 (en) 2013-08-28 2016-04-19 Presbyopia Therapies Llc Compositions and methods for the improvement of distance vision and the treatment of refractive errors of the eye
RU2533276C1 (ru) * 2013-10-09 2014-11-20 Станислав Анатольевич Кедик Глазные капли на основе композиции фармацевтически приемлемой аддитивной соли кислоты и метилэтилпиридинола и таурина, содержащие композицию витаминов группы в
RU2528912C1 (ru) * 2013-10-09 2014-09-20 Станислав Анатольевич Кедик Глазные капли на основе композиции фармацевтически приемлемой аддитивной соли кислоты и метилэтилпиридинола, содержащие композицию витаминов группы в
WO2015162494A2 (en) * 2014-02-25 2015-10-29 Mitotech, S.A. Cosmetic compositions of mitochonrially targeted antioxidants
US20170128467A1 (en) * 2014-05-30 2017-05-11 Friehoff Lawrence T Antimicrobial pharmaceutical compositions with multiple drug resistance inhibiting properties
WO2016013993A1 (en) 2014-07-25 2016-01-28 Imuneks Farma Llac Sanayi Ve Ticaret A.Ş. Stable preservative free ophthalmic formulations of opioid antagonists
WO2016200364A1 (en) * 2015-06-08 2016-12-15 Stealth Peptides International, Inc. THERAPEUTIC COMPOSITIONS INCLUDING SkQ COMPOUNDS AND USES THEREOF
CN107312194A (zh) * 2017-07-13 2017-11-03 温州嘉泰乳胶制品有限公司 乳胶固化配方工艺
WO2019204401A1 (en) * 2018-04-19 2019-10-24 Presbyopia Therapies Llc Compositions and methods for the treatment of presbyopia
CN111351886B (zh) * 2018-12-24 2023-06-23 成都平和安康医药科技有限公司 一种测定酚磺乙胺药物中含有的杂质及其主药含量的方法
EP4072512A4 (en) * 2019-12-10 2024-01-10 Mitotech S.A. POLYMERIC MATRIXES FOR DIFFERENT COMPOSITIONS OF MITOCHONDRIAL TARGETED ANTIOXIDANTS
RU2768752C1 (ru) * 2020-12-24 2022-03-24 Общество с ограниченной ответственностью "Международная лаборатория "Резистом" Противовирусная композиция для защиты растений на основе поли(а):поли(у)
US11648247B1 (en) 2021-12-16 2023-05-16 Lenz Therapeutics, Inc. Compositions and methods for the treatment of presbyopia

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07252149A (ja) * 1994-01-27 1995-10-03 Senju Pharmaceut Co Ltd 眼科用剤
US5538974A (en) * 1994-01-27 1996-07-23 Senju Pharamceutical Co., Ltd. Ophthalmic composition for lowering intraocular pressure
US5535974A (en) * 1994-03-07 1996-07-16 Savitski; Richard H. Scaffold bracket
US6331532B1 (en) 1998-11-25 2001-12-18 University Of Otago Mitochondrially targeted antioxidants
ATE296305T1 (de) 1997-11-25 2005-06-15 Antipodean Biotechnology Ltd Antioxidantien mit spezifischer wirkung auf mitochondrien
US20080275005A1 (en) 1998-11-25 2008-11-06 Murphy Michael P Mitochondrially targeted antioxidants
US20070270381A1 (en) 2000-05-25 2007-11-22 Antipodean Pharmaceuticals, Inc. Mitochondrially targeted antioxidants
JP2001172183A (ja) * 1999-12-21 2001-06-26 Wakamoto Pharmaceut Co Ltd 眼科用医薬組成物
US20020044913A1 (en) 2000-02-11 2002-04-18 Hamilton Nathan D. Cosmetics to support skin metabolism
JP4859283B2 (ja) * 2001-05-23 2012-01-25 学校法人近畿大学 高安定性抗白内障医薬組成物
ITRM20010755A1 (it) 2001-12-20 2003-06-20 Simonelli Giuseppe Uso del chinone q10 per il trattamento delle malattie oculari.
US6984636B2 (en) 2002-08-12 2006-01-10 Medical Research Council Mitochondrially targeted antioxidants
ES2541769T3 (es) * 2003-08-22 2015-07-24 Antipodean Pharmaceuticals, Inc. Derivados de mitoquinona usados como antioxidantes dirigidos a las mitocondrias
CA2583087C (en) 2003-09-19 2012-07-10 Galileo Pharmaceuticals, Inc. Chroman derivatives
RU2007105138A (ru) 2004-07-13 2008-08-20 Оридис Биомед Форшунгс-Унд Энтвиклунгс Гмбх (At) Применение митохондриально направленного антиоксиданта при лечении болезней печени и эпителиальных раковых опухолей
US20070259908A1 (en) 2004-08-30 2007-11-08 Kaneka Corporation Mitochondria Activators
RU2318500C2 (ru) 2005-10-18 2008-03-10 Общество С Ограниченной Ответственностью "Митотехнология" Способ воздействия на организм путем адресной доставки биологически активных веществ в митохондрии, фармацевтическая композиция для его осуществления и соединение, применяемое для этой цели
EP2119436A4 (en) 2006-10-20 2010-03-03 Ltd Liability Company Mitotech PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF EYE DISEASES
US8518915B2 (en) 2007-06-29 2013-08-27 Mitotech Sa Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases
JP2009091175A (ja) * 2007-10-04 2009-04-30 Sumitomo Electric Ind Ltd ＧａＮエピタキシャル基板、半導体デバイス、ＧａＮエピタキシャル基板及び半導体デバイスの製造方法
EP2303824B1 (en) 2008-06-25 2015-03-25 Edison Pharmaceuticals, Inc. 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
EA201101576A1 (ru) * 2009-04-28 2012-04-30 Эдисон Фармасьютикалз, Инк. Лекарственная форма токотриенол хинонов для лечения офтальмических (глазных) заболеваний

Also Published As

Publication number Publication date
CN107362157B (zh) 2022-08-26
US9724313B2 (en) 2017-08-08
CN107362157A (zh) 2017-11-21
US20120094962A1 (en) 2012-04-19
ZA201200111B (en) 2012-09-26
AU2009347921A1 (en) 2012-01-19
ES2527791T3 (es) 2015-01-29
EP2823814A1 (en) 2015-01-14
AU2009347921B2 (en) 2014-07-17
KR101478728B1 (ko) 2015-01-02
KR20130082069A (ko) 2013-07-18
JP5659388B2 (ja) 2015-01-28
US10213392B2 (en) 2019-02-26
WO2010143990A1 (ru) 2010-12-16
IL216702A0 (en) 2012-02-29
MX2011013150A (es) 2012-03-14
EP2441453A1 (en) 2012-04-18
CN102548548B (zh) 2017-09-01
CA2764481C (en) 2015-11-24
US20170304225A1 (en) 2017-10-26
BRPI0924460A2 (pt) 2018-03-27
CN102548548A (zh) 2012-07-04
JP2012529504A (ja) 2012-11-22
CA2764481A1 (en) 2010-12-16
AU2009347921B8 (en) 2014-07-24
EP2441453B1 (en) 2014-11-26
EP2441453A4 (en) 2013-04-10
EA025414B1 (ru) 2016-12-30
EA201101518A1 (ru) 2012-04-30

Similar Documents

Publication Publication Date Title
UA104320C2 (ru) Фармацевтическая композиция на основе митохондриально-адресованного антиоксиданта для применения в медицинской и ветеринарной офтальмологии
MX2011008616A (es) Peptidos utiles en el tratamiento y/o cuidado de la piel , mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
MY155649A (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
CU24117B1 (es) Derivados de la piridina de tieno (2,3-b) como inhibidores virales de la réplica
IN2012DN06720A (ko)
WO2013186777A3 (en) Use of blocking agents of bone morphogenie protein (bmp) signaling for the treatment of neuroinflammatory and neurodegenerative diseases
EA201290171A1 (ru) Вводимые перорально кортикостероидные композиции
MY186106A (en) Diagnosis, prevention and treatment of diseases of the joint
ES2397889A1 (es) PÉPTIDOS MODULADORES DE PGC-1Alfa.
PH12019501363A1 (en) Insulin containing pharmaceutical compositions
PH12015500823A1 (en) Modified release formulations for oprozomib
EA201391689A1 (ru) Система доставки лекарственного средства
GEP20156332B (en) Pyrazoles as crth2 antagonists
MX2015007731A (es) Formulacion farmaceutica que comprende ciclesonida.
MX341660B (es) Agonista del receptor de ghrelina para el tratamiento de caquexia.
WO2011058245A8 (fr) Nouveaux derives de mannopyranoside ayant une activite anticancereuse
MX2019002657A (es) Combinaciones con un peptido con esqueleto ciclado.
MX2019002894A (es) Combinaciones con un peptido ciclado con la estructura de la base.
PH12015500070B1 (en) Pediatric oral liquid compositions containing nepadutant
MY159675A (en) Clerodane derivatives for modulation of leukotriene receptor activity and related diseases
NZ713490A (en) Oral suspension for treating eosinophilic esophagitis
ZA202104321B (en) Aqueous paediatric retinol formulations
Fabiny Ask the doctor. I recently took antibiotics to treat an oral infection and as a result developed a vaginal yeast infection. Can I treat it myself, and what are the most effective options?
UA44342U (ru) Способ восстановления слёзоотводных путей при травматических повреждениях средней зоны лица
EA201992775A2 (ru) Конъюгаты антител человека против тканевого фактора с лекарственными препаратами